Average Co-Inventor Count = 7.37
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (8 from 2,078 patents)
2. Janssen Pharmaceuticals, Inc. (5 from 159 patents)
3. Katholieke Universiteit Leuven (4 from 346 patents)
4. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
5. Kathalieke Universiteif Leuven (1 from 1 patent)
14 patents:
1. 11795149 - Substituted indoline derivatives as dengue viral replication inhibitors
2. 11702387 - Substituted indoline derivatives as dengue viral replication inhibitors
3. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
4. 11407715 - Substituted indoline derivatives as dengue viral replication inhibitors
5. 11083707 - Substituted indoline derivatives as dengue viral replication inhibitors
6. 11053196 - Substituted indoline derivatives as dengue viral replication inhibitors
7. 9227935 - Piperidine/piperazine derivatives
8. 8981094 - Piperidine/piperazine derivatives
9. 8946228 - Piperidine/piperazine derivatives
10. 8633197 - Piperidine/piperazine derivatives
11. 7803823 - 2-amino-4,5-trisubstituted thiazolyl derivatives
12. 7511068 - Mercaptoimidazoles as CCR2 receptor antagonists
13. 7232838 - 2-amino-4,5-trisubstituted thiazolyl derivatives
14. 6911444 - Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors